ReviewEuropean journal of clinical pharmacology2026
Beyond safety: adverse events and unanticipated advantages of SGLT2 inhibitors.
Lorenzo Falsetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it